Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension
2018 · Thorax · 52 citations
https://doi.org/10.1136/thoraxjnl-2017-211440
M
Mark L. Ormiston
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
3.6K
Citations
26
h-index
35
i10-index
Mark L. Ormiston is an academic researcher from University of Zurich. The author has contributed to research in topics: Pulmonary Hypertension Research and Treatments & Angiogenesis and VEGF in Cancer & IL-33, ST2, and ILC Pathways. The author has an h-index of 26, co-authored 73 publications.
ORCID: 0000-0003-0907-1940Papers by this author
worksMonitoring the 5′UTR landscape reveals isoform switches to drive translational efficiencies in cancer
2022 · Oncogene · 51 citations
https://doi.org/10.1038/s41388-022-02578-2
In vivo single-cell CRISPR uncovers distinct TNF programmes in tumour evolution
2024 · Nature · 26 citations
https://doi.org/10.1038/s41586-024-07663-y
A sex-specific reconstitution bias in the competitive CD45.1/CD45.2 congenic bone marrow transplant model
2017 · Scientific Reports · 25 citations
https://doi.org/10.1038/s41598-017-03784-9
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension
2024 · Hypertension · 15 citations
https://doi.org/10.1161/hypertensionaha.124.22822
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat